Skip to main content
. 2018 Sep 12;67(12):1853–1862. doi: 10.1007/s00262-018-2236-7

Fig. 3.

Fig. 3

Histopathology results from patient 3 (with progressive disease, treated on phase 1 after 3 induction doses on the GM.CD40L.CCL21 vaccine). At week 7, the patient underwent a biopsy of a liver lesion after cycle 1 day 1 of the vaccine. A moderate-to-high infiltration of CD3+ and CD45+ T cells is shown. FNA fine needle aspiration; H&E hematoxylin and eosin